We're building a better ClinicalTrials.gov. Check it out and tell us what you think!

Key Record Dates

ClinicalTrials.gov Identifier: NCT01506973
Brief Title: A Phase I/II/Pharmacodynamic Study of Hydroxychloroquine in Combination With Gemcitabine/Abraxane to Inhibit Autophagy in Pancreatic Cancer

First Submitted : January 3, 2012
First Submitted that Met QC Criteria : January 9, 2012
First Posted : January 10, 2012 (Estimate)

Last Update Submitted that Met QC Criteria : March 29, 2022
Last Update Posted : March 31, 2022